# Chegg, Inc: financial statements, quarterly

CHGG · NYSE · CIK 1364954 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chgg.md) · [Financials](/companies/chgg/financials.md) · [Filings](/companies/chgg/filings.md) · [Insiders](/companies/chgg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chgg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [158](/filings/0001364954-24-000085.md) | [188 d](/filings/0001364954-26-000021.md) | [174](/filings/0001364954-25-000052.md) | [163](/filings/0001364954-25-000096.md) | [137](/filings/0001364954-25-000117.md) | [143 d](/filings/0001364954-26-000021.md) | [121](/filings/0001364954-26-000048.md) | [105](/filings/0001364954-26-000088.md) | [77.7](/filings/0001364954-25-000117.md) | [72.7 d](/filings/0001364954-26-000021.md) | [63.3](/filings/0001364954-26-000048.md) | [51.8](/filings/0001364954-26-000088.md) |
| Cost of revenue | $m | [83.6](/filings/0001364954-24-000085.md) | [45.8 d](/filings/0001364954-26-000021.md) | [46.5](/filings/0001364954-25-000052.md) | [45.4](/filings/0001364954-25-000096.md) | [43.4](/filings/0001364954-25-000117.md) | [45.6 d](/filings/0001364954-26-000021.md) | [54.0](/filings/0001364954-26-000048.md) | [35.5](/filings/0001364954-26-000088.md) | [31.7](/filings/0001364954-25-000117.md) | [31.0 d](/filings/0001364954-26-000021.md) | [25.4](/filings/0001364954-26-000048.md) | [23.6](/filings/0001364954-26-000088.md) |
| Gross profit | $m | [74.3](/filings/0001364954-24-000085.md) | [142 d](/filings/0001364954-26-000021.md) | [128](/filings/0001364954-25-000052.md) | [118](/filings/0001364954-25-000096.md) | [93.2](/filings/0001364954-25-000117.md) | [97.9 d](/filings/0001364954-26-000021.md) | [67.4](/filings/0001364954-26-000048.md) | [69.6](/filings/0001364954-26-000088.md) | [46.0](/filings/0001364954-25-000117.md) | [41.7 d](/filings/0001364954-26-000021.md) | [37.9](/filings/0001364954-26-000048.md) | [28.3](/filings/0001364954-26-000088.md) |
| Research and development | $m | [46.2](/filings/0001364954-24-000085.md) | [45.7 d](/filings/0001364954-26-000021.md) | [44.4](/filings/0001364954-25-000052.md) | [43.7](/filings/0001364954-25-000096.md) | [41.3](/filings/0001364954-25-000117.md) | [41.0 d](/filings/0001364954-26-000021.md) | [29.4](/filings/0001364954-26-000048.md) | [28.7](/filings/0001364954-26-000088.md) | [18.4](/filings/0001364954-25-000117.md) | [17.0 d](/filings/0001364954-26-000021.md) | [9.1](/filings/0001364954-26-000048.md) | [7.4](/filings/0001364954-26-000088.md) |
| Operating income | $m | [(57.9)](/filings/0001364954-24-000085.md) | [13.3 d](/filings/0001364954-26-000021.md) | [(2.5)](/filings/0001364954-25-000052.md) | [(485)](/filings/0001364954-25-000096.md) | [(222)](/filings/0001364954-25-000117.md) | [(27.3) d](/filings/0001364954-26-000021.md) | [(29.0)](/filings/0001364954-26-000048.md) | [(36.5)](/filings/0001364954-26-000088.md) | [(17.1)](/filings/0001364954-25-000117.md) | [(34.3) d](/filings/0001364954-26-000021.md) | [(1.0)](/filings/0001364954-26-000048.md) | [(3.2)](/filings/0001364954-26-000088.md) |
| Interest expense | $m | [0.7](/filings/0001364954-24-000085.md) | [0.7 d](/filings/0001364954-26-000021.md) | [0.7](/filings/0001364954-25-000052.md) | [0.7](/filings/0001364954-25-000096.md) | [0.7](/filings/0001364954-25-000117.md) | [0.6 d](/filings/0001364954-26-000021.md) | [0.5](/filings/0001364954-26-000048.md) | [0.0](/filings/0001364954-26-000088.md) | [0.0](/filings/0001364954-25-000117.md) | [0.0 d](/filings/0001364954-26-000021.md) | [0.0](/filings/0001364954-26-000048.md) | [0.0](/filings/0001364954-26-000088.md) |
| Income tax | $m | [0.2](/filings/0001364954-24-000085.md) | [8.1 d](/filings/0001364954-26-000021.md) | [9.1](/filings/0001364954-25-000052.md) | [138](/filings/0001364954-25-000096.md) | [(2.7)](/filings/0001364954-25-000117.md) | [4.0 d](/filings/0001364954-26-000021.md) | [1.0](/filings/0001364954-26-000048.md) | [1.2](/filings/0001364954-26-000088.md) | [1.7](/filings/0001364954-25-000117.md) | [(0.6) d](/filings/0001364954-26-000021.md) | [(0.1)](/filings/0001364954-26-000048.md) | [0.4](/filings/0001364954-26-000088.md) |
| Net income | $m | [(18.3)](/filings/0001364954-24-000085.md) | [9.7 d](/filings/0001364954-26-000021.md) | [(1.4)](/filings/0001364954-25-000052.md) | [(617)](/filings/0001364954-25-000096.md) | [(213)](/filings/0001364954-25-000117.md) | [(6.1) d](/filings/0001364954-26-000021.md) | [(17.5)](/filings/0001364954-26-000048.md) | [(35.7)](/filings/0001364954-26-000088.md) | [(17.5)](/filings/0001364954-25-000117.md) | [(32.8) d](/filings/0001364954-26-000021.md) | [0.2](/filings/0001364954-26-000048.md) | [(3.0)](/filings/0001364954-26-000088.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001364954-24-000085.md) | not reported | [(0.01)](/filings/0001364954-25-000052.md) | [(6.01)](/filings/0001364954-25-000096.md) | [(2.05)](/filings/0001364954-25-000117.md) | not reported | [(0.17)](/filings/0001364954-26-000048.md) | [(0.33)](/filings/0001364954-26-000088.md) | [(0.16)](/filings/0001364954-25-000117.md) | not reported | [0.00](/filings/0001364954-26-000048.md) | [(0.03)](/filings/0001364954-26-000088.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001364954-24-000085.md) | not reported | [(0.01)](/filings/0001364954-25-000052.md) | [(6.01)](/filings/0001364954-25-000096.md) | [(2.05)](/filings/0001364954-25-000117.md) | not reported | [(0.17)](/filings/0001364954-26-000048.md) | [(0.33)](/filings/0001364954-26-000088.md) | [(0.16)](/filings/0001364954-25-000117.md) | not reported | [0.00](/filings/0001364954-26-000048.md) | [(0.03)](/filings/0001364954-26-000088.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [94.4](/filings/0001364954-24-000085.md) | [136](/filings/0001364954-26-000021.md) | [144](/filings/0001364954-25-000052.md) | [133](/filings/0001364954-25-000096.md) | [152](/filings/0001364954-25-000117.md) | [161](/filings/0001364954-26-000021.md) | [44.1](/filings/0001364954-26-000048.md) | [36.8](/filings/0001364954-26-000088.md) | [38.2](/filings/0001364954-25-000117.md) | [31.1](/filings/0001364954-26-000021.md) | [33.5](/filings/0001364954-26-000048.md) | [44.6](/filings/0001364954-26-000088.md) |
| Current assets | $m | [348](/filings/0001364954-23-000146.md) | [415](/filings/0001364954-25-000013.md) | [466](/filings/0001364954-24-000042.md) | [434](/filings/0001364954-24-000072.md) | [497](/filings/0001364954-24-000085.md) | [438](/filings/0001364954-26-000021.md) | [210](/filings/0001364954-25-000052.md) | [204](/filings/0001364954-25-000096.md) | [203](/filings/0001364954-25-000117.md) | [122](/filings/0001364954-26-000088.md) | [111](/filings/0001364954-26-000048.md) | [109](/filings/0001364954-26-000088.md) |
| Total assets | $m | [1,805](/filings/0001364954-23-000146.md) | [1,727](/filings/0001364954-25-000013.md) | [1,733](/filings/0001364954-24-000042.md) | [1,114](/filings/0001364954-24-000072.md) | [1,003](/filings/0001364954-24-000085.md) | [869](/filings/0001364954-26-000021.md) | [439](/filings/0001364954-25-000052.md) | [404](/filings/0001364954-25-000096.md) | [378](/filings/0001364954-25-000117.md) | [278](/filings/0001364954-26-000088.md) | [244](/filings/0001364954-26-000048.md) | [228](/filings/0001364954-26-000088.md) |
| Current liabilities | $m | [150](/filings/0001364954-23-000146.md) | [518](/filings/0001364954-25-000013.md) | [505](/filings/0001364954-24-000042.md) | [485](/filings/0001364954-24-000072.md) | [546](/filings/0001364954-24-000085.md) | [528](/filings/0001364954-26-000021.md) | [171](/filings/0001364954-25-000052.md) | [227](/filings/0001364954-25-000096.md) | [215](/filings/0001364954-25-000117.md) | [141](/filings/0001364954-26-000088.md) | [107](/filings/0001364954-26-000048.md) | [93.0](/filings/0001364954-26-000088.md) |
| Total liabilities | $m | [771](/filings/0001364954-23-000146.md) | [783](/filings/0001364954-25-000013.md) | [769](/filings/0001364954-24-000042.md) | [749](/filings/0001364954-24-000072.md) | [818](/filings/0001364954-24-000085.md) | [676](/filings/0001364954-26-000021.md) | [253](/filings/0001364954-25-000052.md) | [247](/filings/0001364954-25-000096.md) | [232](/filings/0001364954-25-000117.md) | [158](/filings/0001364954-26-000088.md) | [123](/filings/0001364954-26-000048.md) | [109](/filings/0001364954-26-000088.md) |
| Shareholders' equity | $m | [1,033](/filings/0001364954-24-000085.md) | [945](/filings/0001364954-26-000021.md) | [963](/filings/0001364954-25-000096.md) | [366](/filings/0001364954-25-000117.md) | [185](/filings/0001364954-25-000117.md) | [193](/filings/0001364954-26-000088.md) | [186](/filings/0001364954-26-000088.md) | [158](/filings/0001364954-26-000088.md) | [146](/filings/0001364954-25-000117.md) | [120](/filings/0001364954-26-000088.md) | [121](/filings/0001364954-26-000088.md) | [119](/filings/0001364954-26-000088.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.8 d](/filings/0001364954-24-000085.md) | [77.5 d](/filings/0001364954-26-000021.md) | [53.3](/filings/0001364954-25-000052.md) | [14.2 d](/filings/0001364954-25-000096.md) | [39.5 d](/filings/0001364954-25-000117.md) | [18.1 d](/filings/0001364954-26-000021.md) | [24.5](/filings/0001364954-26-000048.md) | [(4.8) d](/filings/0001364954-26-000088.md) | [4.8 d](/filings/0001364954-25-000117.md) | [(9.0) d](/filings/0001364954-26-000021.md) | [4.1](/filings/0001364954-26-000048.md) | [10.1 d](/filings/0001364954-26-000088.md) |
| Capital expenditure | $m | [23.4 d](/filings/0001364954-24-000085.md) | [25.8 d](/filings/0001364954-26-000021.md) | [28.0](/filings/0001364954-25-000052.md) | [17.8 d](/filings/0001364954-25-000096.md) | [15.8 d](/filings/0001364954-25-000117.md) | [13.3 d](/filings/0001364954-26-000021.md) | [8.7](/filings/0001364954-26-000048.md) | [7.2 d](/filings/0001364954-26-000088.md) | [5.8 d](/filings/0001364954-25-000117.md) | [6.5 d](/filings/0001364954-26-000021.md) | [1.0](/filings/0001364954-26-000048.md) | [3.7 d](/filings/0001364954-26-000088.md) |
| Share repurchases | $m | [0.0 d](/filings/0001364954-24-000085.md) | [148 d](/filings/0001364954-26-000021.md) | [0.0](/filings/0001364954-24-000042.md) | [0.0 d](/filings/0001364954-24-000072.md) | [0.0 d](/filings/0001364954-24-000085.md) | [2.6 d](/filings/0001364954-26-000021.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [148](/filings/0001364954-23-000146.md) | [124](/filings/0001364954-24-000042.md) | [133](/filings/0001364954-24-000072.md) | [115](/filings/0001364954-24-000085.md) | [102](/filings/0001364954-25-000052.md) | [103](/filings/0001364954-25-000096.md) | [104](/filings/0001364954-25-000117.md) | [105](/filings/0001364954-26-000048.md) | [107](/filings/0001364954-26-000088.md) | [108](/filings/0001364954-25-000117.md) | [112](/filings/0001364954-26-000048.md) | [111](/filings/0001364954-26-000088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 111,027,482 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001364954-26-000088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.